These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 34816789

  • 21. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC.
    Cancer; 2017 Nov 15; 123(22):4337-4345. PubMed ID: 28743162
    [Abstract] [Full Text] [Related]

  • 22. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.
    Lee CY, Yang KL, Ko HL, Huang RY, Tsai PP, Chen MT, Lin YC, Hwang TI, Juang GD, Chi KH.
    Radiat Oncol; 2014 Sep 24; 9():213. PubMed ID: 25248470
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis.
    Zhou YX, Hu QC, Zhu YJ, Mu XL, Liu JY, Chen Y.
    Eur J Med Res; 2023 Oct 11; 28(1):422. PubMed ID: 37822001
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients.
    Kijima T, Tanaka H, Koga F, Masuda H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.
    BJU Int; 2019 Aug 11; 124(2):242-250. PubMed ID: 30811784
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival.
    Tang Y, Lin L, Xiao Y, Meng L, Yang Y, Li X.
    Clin Transl Oncol; 2024 Feb 11; 26(2):446-455. PubMed ID: 37389736
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D, Gong YQ, Hao H, He ZS, Li XS, Zhang CJ, Zhou LQ.
    BMC Cancer; 2017 Jun 02; 17(1):391. PubMed ID: 28578683
    [Abstract] [Full Text] [Related]

  • 36. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach.
    Inoue M, Koga F, Yoshida S, Tamura T, Fujii Y, Ito E, Kihara K.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):303-11. PubMed ID: 25304790
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka J, Saito K, Kawakami S, Kihara K.
    BJU Int; 2012 Sep 01; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer.
    Ham WS, Park JS, Jang WS, Kim J.
    Ann Surg Oncol; 2024 Feb 01; 31(2):1384-1392. PubMed ID: 37884699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.